← Back to Mission Control

Neurotech Intelligence

BCI · Neuromodulation · NeuroAI 120+ Companies
June 5, 2026 10:00 AM · Notables #55 confirmed, #56 due ~Jun 12-14 · 3 new regulatory milestones added · Quiet week

Total Funding Tracked

$5.8B
119 companies · Updated May 19, 2026

BCI Companies

15+
with human implants / trials

Human Implants

5
Neuralink, Paradromics, Synchron +2

YTD Deals (2026)

~$405M+
across 16+ rounds · Jun 2026

🏆 Top Valued Neurotech Companies

BCI Neuralink
Brain-computer interface · Elon Musk
$9B
Series E · $650M
BCI Precision Neuroscience
Minimally invasive BCI · Layer 7 cortical implant
$543M
Total Raised
BCI Paradromics
High-bandwidth BCI · First human implant done
$500M
Total Raised
BCI Blackrock Neurotech
Utah Array · longest human BCI dataset
$350M
Total Raised
BCI Science Corp
Full-stack neural engineering · restoring/extending life
$230M
Series C · Mar 2026
Clinical Cognito Therapeutics
Spectris platform · Alzheimer's / optical neurostimulation
$105M
Series raise

🌱 New Entrants (2025–2026)

Atlas (Cambridge)
Multi-modal brain-sensing wearable — emerged from stealth May 8, 2026 with $14M Series A to launch EEG wearable next year
New Entrant BCI $14M Series A · May 2026 · Cambridge, MA · Hiring
Kordata (BIOS Health US Spinoff)
AI-powered NeuroTune platform for optimizing treatment dosages in Alzheimer's, Parkinson's, epilepsy — spinoff of UK-based BIOS Health, launching in Bakersfield CA
New Entrant NeuroAI Pre-seed · Kern Venture Group + MAVRK · May 2026 · Bakersfield CA · Hiring 11 locals
Epia Neuro
Therapeutic BCI for stroke recovery — founded by Michel Maharbiz (neural dust) + Gil Mandelbaum
New Entrant BCI Founded 2026 · SF
The Biological Computing Company
Biological computing platform for neural applications
New Entrant BCI Raised $25M Seed · Feb 2026
Phantom Neuro
Neuromuscular BCI for prosthetic control
BCI Actively recruiting · Texas-based
NeuroBionics
Peripheral nerve interface for restoration
BCI Emerging player
Bliss
Culturally adaptive AI therapy chatbot
AI Therapy Raised €233K angel · Apr 2026
Sabi
EEG beanie with 70,000–100,000 sensors translating thought to text — consumer BCI for mass adoption
New Entrant Wearable BCI Backed by Khosla Ventures · Emerged stealth May 2026 · Silicon Valley
Cambridge NeuroWorks
Breakthrough neurotechnology platform — named "Tech for Good" winner for advancing neurotech innovation
New Entrant BCI Cambridge, UK · Awarded May 8, 2026
NeuCyber
Beijing-backed BCI — 7 successful human implantations with Beinao-1 semi-invasive device, comparing to Neuralink
New Entrant BCI Beijing, China · Active 2026
Constellix
Neuromodulation platform (undisclosed details)
Neuromodulation Jan–Feb 2026 activity
Forest Neurotech
Non-invasive ultrasound BCI — Sam Altman-backed. Pioneering non-invasive neural interfaces using ultrasound. Merge Labs parent org.
New Entrant BCI Spin-out Jan 2026 · Palo Alto, CA · Actively Hiring
Connectome Health
Cognitive intelligence platform quantifying brain activity over time — $2M pre-seed, Redstone-led
New Entrant NeuroAI Founded 2026 · Zurich, Switzerland 🇨🇭
PL Neuro (Protocol Labs)
Protocol Labs project — breaking bottlenecks in neural augmentation, biologically-inspired intelligence, and whole organism emulation.
New Entrant NeuroAI Launched May 2026 · Protocol Labs / Silicon Valley

🌍 Non-US Neurocos Ready for US Entry — Jordan's Sales Targets Hot

Non-US neuro companies actively seeking US partners, distribution, or market expansion. Highest-probability outreach targets — English-speaking sales/partner role.
🔥 Actively Seeking US Partners — Reach Out NOW
🔥 Top Priority — CEO on record seeking US partners
🇳🇱🇩🇪 Zander Labs (Netherlands / Germany)
€30M contract
Passive BCI (pBCI) — detects mental state (focus, workload, intent) subconsciously. Privacy-first. Targets defense, robotics, healthcare, air traffic.
US Signal: Officially entering US in 2026. CEO Jonathan Zwaan on record: "actively seeking US partners on the West Coast." Building partner ecosystem from scratch.
BCI NeuroAI 🎯 US Partner Search
🇧🇪 Nobi (Belgium)
€35M ($37M) Series B
AI smart lights for elderly care — 51% fall reduction, 94% faster caregiver response. In 22 countries. US office already open.
US Signal: Explicitly using Series B to expand into US + UK markets. Building B2B care home channel.
AgeTech US Office ✓
🇫🇷 Hilo (France)
$100M+ total · $42M Series B
AI-powered smart glasses — memory, focus, productivity. Consumer "neuro intelligence" wearable. "Next generation of cognitive performance."
US Signal: Raised $42M Series B (2025) explicitly to expand. French company going global — US consumer market is the prize.
Cognitive Wearable Neuro Intelligence
🌏 SE Asia — Actively Raising US Round
🔥 SynPhNe — CEO on record raising US round RIGHT NOW
🇸🇬 SynPhNe — RAISING US 🔥
$5M Series A (Part 1 done)
NTU spinoff. Wearable BCI synchronizes cognition + motor function for stroke/TBI rehab. Clinically validated. Partnership with Indegene (US medtech distributor).
US Signal: CEO: "Raising Part 2 of Series A, focused on scaling in the US." Target: $2M first US revenue. Needs US sales/channel partner ASAP.
Stroke / TBI Rehab BCI Wearable Raising US Round
🟡 Strong Non-US Players — US Expansion Underway
🇪🇸 INBRAIN Neuroelectronics (Spain — Barcelona)
$50M Series B
Graphene-based bidirectional BCI — world's first human enrollment with graphene neural interfaces. Medical/therapeutic.
US Signal: Series B with imec. Pursuing US regulatory + commercial path. One of Europe's largest neurotech rounds.
BCI Clinical First Human ✓
🇦🇺 Emotiv (Australia)
Institutional
Wireless EEG headsets + software platform. 20M+ people have used their tech. Tan Le (founder) is high-profile. Sells heavily in North America.
US Signal: Already has SF office. Less "entry" need — more "accelerate US presence" need.
BCI NeuroAI US Office ✓
🇬🇧 Cerca Magnetics (UK)
€4.3M Seed (2025)
Wearable brain imaging using quantum sensing (OPM). Less intrusive than traditional EEG.
US Signal: UK startup, likely seeking global expansion post-seed.
Quantum Sensing BCI
🇱🇻 Qualia Therapeutics (Latvia — Riga)
Undisclosed
AI-driven non-invasive brain therapy. Niche, early-stage.
NeuroAI Therapy
🟢 Southeast Asia — Neuro Health + BCI Startups
🇸🇬 Singapore
SynPhNe — ACTIVE US RAISE NOW 🔥
$5M Series A (Part 1 done)
NTU spinoff. Wearable BCI for stroke/TBI rehab — synchronizes cognition + motor function. CEO: "Raising Part 2 of Series A, focused on scaling in the US." First US revenue = $2M target.
US Signal: Actively raising US-focused Series A RIGHT NOW. Partnership with Indegene (US medtech). Needs US sales/distributor partner.
Stroke / TBI Rehab BCI Wearable Raising US Round
🇸🇬 Singapore
Intellect — Asia's best-funded mental health startup
$20M+ Series A
Digital mental health platform — self-care tools, coaching, therapy, 24/7 EAP. "Largest Series A ever raised by a mental health startup in Asia." Softbank-backed.
US Signal: Scaling across Asia. Strong B2B mental health product. Global expansion is the next phase.
Mental Health Best-Funded Asia Mental Health
🇸🇬 Singapore
NeuroDrive — Early Stage, Hot Signal
~$120K Raised
Palm-sized AI BCI for paralyzed patients — allows communication via blinks in 10 seconds. Founded early 2025 by Singapore Polytechnic grads. Top 200 Early-Stage Startups — TechCrunch.
US Signal: Won ~$120K (RMB 650K) in cash prizes. Small now but founder energy is high. Could be big with US clinical partners.
BCI Assistive Early Stage
🇸🇬 Singapore
Neeuro
A*STAR Backed
EEG cognitive monitoring platform + SenzeBand headband. Brain health applications, cognitive training. Strategic MOU with Chongqing Yunnao for China BCI healthcare market.
US Signal: A*STAR backed, solid EEG IP. B2B platform play — could partner with US healthcare systems.
EEG Platform Cognitive Health
🇸🇬 Singapore
Neurowyzr
$2.1M+ Seed
Neuroscience clinic + Digital Brain Function Screen (DBFS). Cognitive decline detection, brain health assessment. Backed by Peak XV Surge + Jungle Ventures.
US Signal: Early stage, primarily SG/MY market. Could grow to US with right partner or US distributor.
Cognitive Assessment Early Stage

💰 Recent Deals (May–Jun 2026)

Omniscient Neurotechnology
$27.2M · Series D
New BCI Connectomics-driven clinical + BCI applications · Sydney · May 28, 2026
Sound Wave
~$17M · Round
New Clinical Japanese Alzheimer's startup · WSJ reported · May 2026
Psilera
$8.8M · Seed
New Neuroplastogen PSIL-006 for clinical psilocybin · May 2026
ReVision
€4M · Round
New Neuromodulation Oversubscribed European round · May 2026
Medtronic → SPR Therapeutics
$650M · Acquisition
Acquisition Regulatory Chronic pain BCI/neuromodulation · MedTech giant expands · May 2026
Nexalin
Platform Acquisition
Acquisition Neuromodulation HALO™ Clarity + Nexalin NeuroCare™ AI platform · FDA pivotal trial planned · May 2026
Neurosoft Bioelectronics
$7.5M · Seed
New BCI Soft/stretchable cortical BCI · Swiss/US · May 20, 2026
Atlas
$14M · Series A
New BCI Brain-sensing EEG wearable · Cambridge, MA · May 2026
ResMed → Noctrix
$360M · Acquisition
Acquisition Restless leg syndrome device maker · ~$24M ARR · Apr 2026
Science Corp
$230M · Series C
BCI Full-stack neural engineering · Alameda, CA · Mar 2026
Mobia Medical
$150M · IPO
New BCI Listed May 2026 · Oman Investment Authority backs Neuralink
BlueWind Medical
$47.8M · Growth
Neuromodulation Revi® bladder system · Commercialization push · May 2026
SonoMind
€20M · Series A
New Neuromodulation Non-invasive treatment-resistant depression therapy · May 2026
Ampa
~$17M · Round
New Neuromodulation Portable TMS depression platform · Tim Ferriss backed · May 2026
EBT Medical + NinaMED
$13.75M
Neuromodulation NiNA System® overactive bladder · May 2026
Nexstim Plc
€5M · Investment
FDA Eiffel + Brainlab investment · May 2026
Connectome Health
$2M · Pre-Seed
New NeuroAI Cognitive intelligence platform · Redstone · Zurich · Apr 2026
Coherence Neuro
$10M · Seed
New BCI SOMA-1 closed-loop neuro for cancer treatment · SF · Mar 2026
Axoft
$55M · Series A
New BCI Bio-inspired implantable BCI · Testing in China
Nervonik
$52.5M · Series B
Neuromodulation Peripheral nerve stimulation · Amzak Health led
Cala Health
$50M · Growth
Neuromodulation Wearable tremor therapy · Trinity Capital
ANEUVO
$22M · Series C
FDA Cleared ExaStim spinal cord stimulation · May 2026
Beacon Biosignals
$97M · Series B ext.
NeuroAI EEG analytics platform · Apr 2026
neuroClues
€10M · Series A
New BCI Teampact.ventures + EIC Fund · Apr 2026
StairMed
$75M
BCI Alibaba-led round · Mar 2026
WHOOP
$575M · Jumbo
Wearable $10.1B valuation · Mar 2026
The Biological Computing Company
$25M Seed
New Primary VC · Feb 2026
Bliss (AI Therapy)
€233K Angel
AI Therapy Culturally adaptive · Apr 2026
Cerca Magnetics
£3.8M · Series A
New Quantum BCI Quantum brain scanners · UK · Apr 2026
Sinaptica
$9M · Funding
Neuromodulation Precision neuromodulation in Alzheimer's · Apr 2026
Neurava
$4M · NIH Grant
NeuroAI SUDEP risk algorithms for epilepsy · Apr 2026
Bioness → PoNS System
Acquisition
Acquisition Portable Neuromodulation Stimulator acquired by Bioness · Apr 2026

📍 Milestones & Signals (Apr–May 2026)

🔴 Shutdown
Galvani Bioelectronics — Preparing for orderly shutdown. Major exit in the bioelectronic medicine space. GSK + Verily joint venture dissolving.
Neurotech Notables #54 · May 2026
📋 Regulatory
FDA Leadership — Makary stepped down; Diamantas named acting commissioner. Leadership change may affect device approval timelines.
Neurotech Notables #54 · May 2026
🚀 Product Launch
Prophetic Dream Enhancement — Launched two products: Dual ($449, Q4 2026) and Phase ($1,299, Q3 2027). Consumer lucid dreaming BCI.
Neurotech Notables #54 · May 2026
🏥 FDA Trial Approval
Motif Neurotech — FDA IDE approval for therapeutic BCI (DOT device, blueberry-sized) targeting treatment-resistant depression. ARPA-H EVIDENT program participant. Rice University spinout founded 2022.
Rice News · Apr 28, 2026
🤝 Acquisition
ResMed acquires Noctrix — $360M deal for restless leg syndrome device maker (~$24M ARR). ResMed betting on sleep/neuro overlap.
Neurotech Notables #53 · Apr 2026
🔬 Clinical Trial
INBRAIN Neuroelectronics — Completed enrollment for world's first-in-human study of graphene neural interfaces. Barcelona-based.
Neurotech Notables #53 · Apr 2026
📋 FDA TAP / Breakthrough
CorTec Brain Interchange — Accepted into FDA TAP Program. Third patient successfully implanted. First BCI worldwide designated for stroke motor rehab.
Neurotech Notables #52-53 · Apr 2026
🏥 First Human Implants
NeuCyber (China) — 7 successful human implantations with Beinao-1 semi-invasive BCI. Beijing-backed company positioning against Neuralink.
Digital Health News · May 2026
🏆 Tech for Good
Cambridge NeuroWorks — Named "Tech for Good" winner for advancing breakthrough neurotechnology. Awarded May 8, 2026.
Cambridge NeuroWorks · May 8, 2026
🤝 Partnership
MintNeuro + Motif Neurotech — Partnership to advance miniature BCI therapy for mental health. Precision Neuroscience + UChicago Medicine — BCI research collaboration.
Neurotech Notables #53 · Apr 2026
🔬 Clinical Trial
Synchron INTENT trial — FDA-permitted third clinical trial of Stentrode BCI started. SetPoint Medical enrolled first MS patients in neuroimmune modulation study.
Neurotech Notables #52 · Apr 2026
🏥 First Human Implant
Paradromics completes first human BCI implant — actively collecting patient data for Connexus speech BCI.
CNBC · June 2025
📋 Regulatory
RAPID Coverage Pathway — New joint CMS + FDA initiative to accelerate patient access to "life-changing" medical devices. Over 115 devices now enrolled in FDA TAP program.
Neurotech Notables #53 · Apr 2026
🔬 Research Breakthrough
Columbia Engineering BISC — Flexible BCI chip with 65,536 electrodes unveiled. World's highest-density flexible neural interface.
Neurotech Notables #53 · Apr 2026
🏥 Clinical Enrollment
ONWARD Medical — First participant enrolled in global study for blood pressure instability after spinal cord injury.
Neurotech Notables #53 · Apr 2026
📍 Upcoming Event
Neurolief at APA Annual Meeting (May 16–20, SF) — Showcase of Proliv®Rx FDA-approved at-home brain stimulation for MDD. KOL panel May 18. 31.7% remission rate at 16 weeks in MOOD pivotal trial.
PR Newswire · May 2026
💼 Hiring Surge
Cala Health (9 roles incl. Director of Marketing $XXXK — HOT), Nervonik (20+ roles across R&D/Clinical/Reg — growing fast post $52.5M Series B), Science Corp (Digital Marketing $150K–$220K), Merge Labs ("Neuron Whisperer" $165K–$215K SF), LivaNova (Dir Neuromodulation $215K–$250K Austin), huMannity Medtec (Dir PM $192K–$230K Santa Clara), Synchron (Field BCI Specialist $90K–$120K Buffalo), Paradromics (VP Marketing), Beacon Biosignals (BD Manager Boston/Remote 🔥).
Greenhouse/LinkedIn/Careers pages · May 17, 2026
🚀 Product Launch
Zeto NeuroNotis™ — AI-enabled EEG report with human review. FDA 510(k) also secured for Zeto New Wave™ outpatient EEG.
Neurotech Notables #53 · Apr 2026
🔄 Strategic Pivot
Neurable → OEM — Shifting from own-brand smart headphones to global OEM BCI integration. Also building attention-tracking AI for Apple Vision Pro.
Neurotech Notables #53 · Apr 2026
🤝 Acquisition
Bioness acquires PoNS System — Portable Neuromodulation Stimulator changes hands. Neuromodulation market consolidation continues.
Signals 06 · May 15, 2026
💰 Payer Coverage
NeurAxis — Expands payer coverage with four new medical policies. Neuromodulation reimbursement landscape improving.
Signals 06 · May 15, 2026
📋 FDA Clearance
Epineuron — Received FDA 510(k) clearance for Evala® Nerve Stimulator. Non-invasive neurostimulation for pain management.
Neurotech Notables #54 · May 2026
🇪🇺 EU MDR Approval
PlatoCare — Achieved EU MDR approval for first wireless tDCS depression treatment. Major regulatory milestone for non-invasive brain stimulation.
Neurotech Notables #54 · May 2026
🏥 Executive
Leadership Moves — Spark Biomedical appointed Anja Krammer as CEO. NeuWire Medical named Ramin Mousavi Executive Chairman. Control Bionics added Nicholas Opie to board.
Neurotech Notables #54 · May 2026
🔬 Research
Psilocybin, Sleep & Parkinson's — Nature: single psilocybin use causes human brain changes. Sleep chart study links sleep duration to biological aging. MYNDspan: MEG scan can classify Parkinson's non-invasively.
Neurotech Notables #54 · May 2026
🏥 Clinical Expansion
Paradromics — Adds third clinical site for Connexus® BCI trial at University of Michigan. Study advancing toward pivotal trial.
Paradromics.com · May 2026
🏥 FDA Trial Approval
ABILITY Neurotech — IMDD Approval to start clinical trial for chronic implantation of brain-computer interface in ALS patients.
Neurotech Notables #55 · Jun 2026
📋 Regulatory
MagVenture / MagStim — FDA 510(k) clearance for accelerated TMS protocols, expanding flexibility for clinics and patients.
Neurotech Notables #55 · Jun 2026
📋 Regulatory
Neuropace — New FDA-approved AI application for RNS® System, designed to streamline iEEG review in PDMS.
Neurotech Notables #55 · Jun 2026

🗺️ Landscape by Category

🧠 BCI
Neuralink · Paradromics · Precision Neuroscience · Blackrock · Phantom Neuro · Synchron · Axoft · Epia Neuro · neuroClues
⚡ Neuromodulation
Cala Health · Nervonik · ANEUVO · Sinaptica · Inbrain · BrainSway · Constellix
🤖 NeuroAI
Beacon Biosignals · Arc Institute + OpenAI · Meta TRIBE · Piramidal + IntraNerve
⌚ Wearables
WHOOP · Oura (neuro features) · Empatica · NextMind
💊 NeuroTech-Therapy
Motif Neurotech · Cognito Therapeutics · Bliss · Sinaptica · Altoida · Neurotrack

📊 Company Directory — All Tracked Companies

Company Funding Focus Location 👔 Jobs
Neuralink $964.2M BCI · Paralysis/blindness tech · Elon Musk San Francisco, CA
Synchron $325.0M Endovascular BCI · No open-brain surgery SF & Brooklyn, NY
SetPoint Medical $200.6M Implantable · Chronic inflammatory diseases Valencia, CA
AstronauTx $195.8M Biotech · Neurodegenerative disease treatments London, UK 🇬🇧
BioSerenity $189.7M Epilepsy diagnosis · Health monitoring · Pierre Frouin Paris, France 🇫🇷
Mindstrong Health $160.0M Neuroscience precision therapy · Paul Dagum Menlo Park, CA
Cala Health $145.0M Bioelectronic medicines · Wearable neurotherapeutics · Kate Rosenbluth Burlingame, CA
MindMaze SA $100.0M VR medical · Neural recovery stimulation Lausanne, Switzerland 🇨🇭
Saluda Medical $140.0M Devices · Chronic neurological conditions Sydney, Australia 🇦🇺
Verge Genomics $134.1M ML for drug discovery · Neurodegenerative diseases San Francisco, CA
Inbrain Neuroelectronics $89.6M Graphene-based high-res neural systems Barcelona, Spain 🇪🇸
Ceribell $88.0M Accessible EEG · Emergency and ICU patients Sunnyvale, CA
Theranica $86.0M Wireless devices · Migraine & pain management Netanya, Israel 🇮🇱
Axoft $55M · Series A Bio-inspired implantable BCI · Testing in China US / China
Nervonik $69.9M · Series B Peripheral nerve stimulation therapy US
Science Corp $66.0M Therapeutic BCI · First human implant imminent San Francisco, CA
Ekso Bionics $70.9M Powered exoskeletons · Physical rehabilitation Richmond, CA
CoMind $60.0M Non-invasive neural hardware and software Cambridge, MA
BrainQ $48.8M AI-powered · Neuro-disorder treatment Jerusalem, Israel 🇮🇱
BrainCheck $43.9M Neurocognitive assessments · Cognitive care solutions San Francisco, CA
Paradromics $34.0M High-volume bidirectional BCI data streaming San Francisco, CA
Neurofenix $14.0M NeuroBall · Stroke rehab through gaming London, UK 🇬🇧
Cumulus Neurosciences $12.7M AI platform · Physiological & digital biomarkers Dublin, Ireland 🇮🇪
NextMind $9.2M Non-invasive EEG-based BCI · Mass market Paris, France 🇫🇷
neuroClues €10M · Series A BCI · Teampact.ventures + EIC Fund Europe
Sinaptica $9M Precision neuromodulation in Alzheimer's US
Winterlight Labs $4.2M Voice recognition · Cognitive decline detection Toronto, Canada 🇨🇦
OpenBCI $4.0M Open-source BCI platform · Biosensing New York, NY
Koniku Microprocessors using wetware biological neurons San Francisco, CA
Humm Wearable patch · Working memory improvement San Francisco, CA
Q30 Innovations Q-Collar · Brain protection from head injuries Boston, MA
WiBotic Wireless charging · Medical/robotic devices Seattle, WA
Ceryx Medical $19.9M Bioelectronic therapies · Heart failure London, UK 🇬🇧
Motif Neurotech ARPA-H + DARPA Therapeutic BCI · Treatment-resistant depression · DOT device Houston, TX
CorTec Brain Interchange System · FDA TAP · Stroke rehab BCI Germany 🇩🇪
Epia Neuro Therapeutic BCI for stroke · Maharbiz + Mandelbaum San Francisco, CA
Forest Neurotech Non-invasive ultrasound BCI · Merge Labs parent · Sam Altman Palo Alto, CA
Connectome Health $2M Pre-Seed Cognitive intelligence platform · Brain health tracking Zurich, Switzerland 🇨🇭
Akili Interactive $239.9M Digital therapeutics · Cognitive deficiency · FDA-approved ADHD game Boston, MA
Empatica AI smartwatch · Seizure detection · FDA-cleared Boston, MA
NeuroPace Closed-loop stimulation · Epilepsy · RNS System Mountain View, CA
MicroTransponder Vagus nerve stimulation · Stroke rehab · Vivona Dallas, TX
BrainsWay Deep TMS · Depression · FDA-cleared Jerusalem, Israel 🇮🇱
Helius Medical PONS device · Tongue neurostimulation · MS · FDA-approved Needham, MA
Advanced Bionics Cochlear implants · Sonova subsidiary Valencia, CA
Inspire Medical Systems Hypoglossal nerve stimulation · Sleep apnea · FDA-approved Minneapolis, MN
Nevro Corp Spinal cord stimulation · Chronic pain · Senza system Redwood City, CA
Neuroelectrics $35.9M StarStim wireless tDCS/tACS · Barcelona-based Barcelona, Spain 🇪🇸
Neuros Medical $64.0M Neurostimulation · Chronic pain · ALTERNATIVE study Cleveland, OH
InteraXon (Muse) $28.8M Consumer EEG headband · Meditation · Focus Toronto, Canada 🇨🇦
NeoSensory $14.2M Haptic vests/wristbands · Sound-to-touch · Hearing impaired San Francisco, CA
Pison $8.4M Gesture control · Neural signals · Military + enterprise Boston, MA
Cognito Therapeutics $105M Spectris platform · Alzheimer's · Optical neurostimulation Cambridge, MA
GenSight Biologics Optogenetics · Vision restoration · Lumecct Paris, France 🇫🇷
Nia Therapeutics Closed-loop neurostimulation · Memory loss · DARPA RAM Philadelphia, PA
BitBrain High-tech BCI equipment · Research EEG/EPsolutions Zaragoza, Spain 🇪🇸
RapidAI Stroke + aneurysm imaging · Angio Suite San Francisco, CA
PSYONIC Bionic limbs · Haptic feedback · Able Squad San Francisco, CA
Insightec Focused ultrasound neural stimulation · Exablate Haifa, Israel 🇮🇱
NeurTX MRI-guided TMS · Addiction + mental health · 2024 founded USA
Neurovia Bioelectronics Transvascular neuromodulation · Endovascular implants · 2024 Geneva, Switzerland 🇨🇭
Argus AI AR neuro-navigation · 3D surgical guidance · Estonia · 2024 Tallinn, Estonia 🇪🇪
Optohive Wearable fNIRS brain imaging · Modular hardware · 2024 Oxford, UK 🇬🇧
Spryte Medical Neuro OCT · 10x imaging resolution · 2023 USA
Hird In-ear EEG headphones · Workplace wellness · Denmark · 2023 Copenhagen, Denmark 🇩🇰
NeuroX Flexible wearable EEG · MCI detection · UK · 2024 London, UK 🇬🇧
NeuFit ANZ DC therapy device · Neural pattern mapping · 2023 USA / Australia 🇦🇺
Flow Neuroscience Medication-free depression · Headset + app · UK London, UK 🇬🇧
Neurable $46.0M EEG for AR/VR · Emotion/intent recognition · Boston Boston, MA
ONWARD Medical ARC Therapy · Spinal cord injury · Blood pressure study Eindhoven, Netherlands 🇳🇱
Healint Migraine tracking · Virtual reality rehab · Singapore Singapore 🇸🇬
NeurOne EEG-based adaptive stimulation · Finland Helsinki, Finland 🇫🇮
Dreem (Moonbird) $57.0M Sleep science · Bio-monitoring headband Paris, France 🇫🇷
XRHealth VR telehealth · Physical + cognitive therapy Boston, MA
Open Water Non-invasive BCI · Optical neural imaging San Francisco, CA
TRIPP VR meditation · Digital wellness · LA Los Angeles, CA
HypnoVR VR anesthesia alternative · Pain relief France 🇫🇷
Thync Neurostimulation wearables · Stress + sleep San Francisco, CA
PlatoScience PlatoWork consumer headset · Cognition boost USA
CarThera Ultrasound brain implant · Alzheimer · France Paris, France 🇫🇷
Neurable $46.0M EEG for AR/VR · Emotion/intent recognition · Boston Boston, MA
Halo Neuroscience $13.0M Neurostimulation wearables · Athletic performance · US Army research San Francisco, CA
Kinova $25.0M Assistive robotics · Healthcare robots Boisbriand, Canada 🇨🇦
BrainCo $7.6M · Series A BCI for education · Focus + meditation wearables Somerville, MA
SEVARO $40.1M · Series B Teleneurology · Stroke care on-demand New York, NY
Neurovalens $27.8M Non-invasive wearables · Sleep + anxiety + metabolism Belfast, UK 🇬🇧
Altoida $26.3M AR + AI · Brain health · Alzheimer's prediction Washington, D.C.
Cumulus Neuro $19.6M · Series A AI cloud platform · Brain physiology · Clinical trials Belfast, UK 🇬🇧
Resolve BioSciences €95M Molecular cartography · Neural tissue mapping Germany 🇩🇪
Omniscient Neuro A$60M Brain mapping · Connectomics · AI neural analysis Sydney, Australia 🇦🇺
Newronika €26.2M Deep brain stimulation · Adaptive neuromodulation Milan, Italy 🇮🇹
Neurolief $25M ProlivRx · At-home brain stimulation · MDD Tel Aviv, Israel 🇮🇱
Aiforia €21.2M AI image analysis · Pathology · Brain tissue Helsinki, Finland 🇫🇮
Cortical Labs $11M Biological computing · DishBrain · Neurons on chips Melbourne, Australia 🇦🇺
Arctic Shores $14.6M AI psychometric tests · Cognitive screening Manchester, UK 🇬🇧
NRG Therapeutics $97M · Series B Mitochondrial drugs · Parkinson's + ALS Cambridge, UK 🇬🇧
Psilera $7.6M · Grant Psychedelic compounds · Non-hallucinogenic mental health Tampa, FL
Viz.ai $249.5M AI stroke detection · Medical imaging Tel Aviv, Israel 🇮🇱
Huma $155.0M Digital health platform · Predictive care London, UK 🇬🇧
Cerecin $189.5M Alzheimer's drugs · Neurodegeneration St. Louis, MO
Kernel $160.0M Non-invasive neuroprosthetics · Human augmentation Los Angeles, CA
Medtronic DBS Public Deep brain stimulation · Parkinson's Minneapolis, MN
Abbott Neuromodulation Public Vagus nerve stimulation · Tremor + Parkinson's Chicago, IL
Boston Scientific NEURO Public Spinal cord + vagus stimulation Marlborough, MA
XP Health Digital neuro biomarkers · Stanford spinout San Francisco, CA
Rune Labs Parkinson's monitoring · Apple Watch + BCI San Francisco, CA
Piramidal NeuroAI · Open-source brain data + AI models Remote
MintNeuro Miniature neural interfaces · Mental health BCI London, UK 🇬🇧
Blackrock Neurotech $350M Utah Array · Longest human BCI dataset Salt Lake City, UT
Nia Therapeutics Closed-loop neurostimulation · Memory loss Philadelphia, PA
StairMed $75M BCI · Alibaba-led round USA
MicroTransponder VNS Vivona · Stroke rehab · Paired VNS Dallas, TX
Nevro Corp Senza system · Spinal cord stimulation Redwood City, CA
Insightec Focused ultrasound · Neuro ablation Haifa, Israel 🇮🇱
ONWARD Medical ARC Therapy · Spinal cord injury Eindhoven, Netherlands 🇳🇱
LivaNova VNS therapy · Epilepsy + depression London, UK 🇬🇧
Neuroelectrics $35.9M StarStim · Wireless tDCS/tACS · Barcelona Barcelona, Spain 🇪🇸
BitBrain BCI research equipment · EEG solutions Zaragoza, Spain 🇪🇸
RapidAI Stroke + aneurysm imaging San Francisco, CA
Neurotrack Cognitive assessment · Digital memory testing San Francisco, CA
Zander Labs 🌍 NL/DE €30M contract Passive BCI · Mental state detection · Neuroadaptive AI · Defense/Robotics Netherlands 🇳🇱 / Germany 🇩🇪
Nobi 🌍 BE €35M ($37M) Series B AI smart lights · Fall detection · AgeTech · 51% fall reduction Belgium 🇧🇪 · US + UK offices
Hilo 🌍 FR $100M+ total · $42M Series B AI smart glasses · Cognitive performance · Memory/focus wearable France 🇫🇷
Intellect 🌍 SG $20M+ Series A Digital mental health · Coaching + therapy · B2B EAP Singapore 🇸🇬
NeuroDrive 🌍 SG ~$120K Raised AI BCI for paralyzed patients · Communication via blinks · TechCrunch Top 200 Singapore 🇸🇬
Neeuro 🌍 SG A*STAR Backed EEG cognitive monitoring platform · SenzeBand hardware · BCI healthcare (China MOU) Singapore 🇸🇬
SynPhNe 🌍 SG 🔥 $5M Series A BCI wearable for stroke/TBI rehab · NTU spinoff · ACTIVE US RAISE · Indegene partner Singapore 🇸🇬
12 companies actively hiring · Source: SeedTable · Neurotech Futures · Updated May 13, 2026

💼 Jobs & Career Intelligence — Neurotech

Sales → Marketing → Operations → Technical. Sources: Neurotech Futures Job Board · LinkedIn · Wellfound · ZipRecruiter · Company careers pages
🔥 Sales & Revenue — HIGH PRIORITY
Paradromics 🔥 SALES
VP of Marketing & Brand — $150K–$220K · Austin TX (on-site)
Narrative + movement building + fundraising. Reports to CEO. Technical fluency required.
→ Apply on LinkedIn
Ampa 🔥 SALES
Sales Executive — $150K–$190K · Remote
Neurotech sales role. Territory management. Medical device or healthtech experience preferred.
→ Apply on ZipRecruiter
⚡ Operations & Business
Neuralink OPS
Product Operations — $68K–$114K · Fremont CA
Non-technical ops role at the world's highest-profile BCI. Close to engineering and clinical teams.
→ neuralink.com/careers
Theranica OPS
Director of Operations — Remote · US (neuromodulation therapeutics)
Manages product delivery lifecycle. Neromodulation / medical device background preferred.
→ neurotechjobs.io
LivaNova OPS
Director, Neuromodulation Project Head — $215K–$250K · Austin TX
P&L ownership for neuromodulation portfolio. Strategy + execution. 5+ years in medtech.
→ neurotechjobs.io
Cala Health OPS
Controller — $190K–$240K · San Mateo CA
CPA, GAAP, Big 4 experience. NetSuite + Medicare revenue cycle. VC-backed medtech scale.
→ jobs.gv.com/jobs/cala-health
Cala Health OPS
Manager, People Operations — $110K–$175K · San Mateo CA
Employee relations, change management, performance management. HR leadership at growth-stage medtech.
→ jobs.gv.com/jobs/cala-health
Cala Health OPS
Revenue Cycle Specialist — Remote
Salesforce + Medicare revenue cycle for wearable neuro device. Medical device or healthtech billing experience.
→ jobs.gv.com/jobs/cala-health
Attune Neurosciences OPS
Clinical Research Manager — $120K–$130K · San Francisco CA
Trial management for anesthesiology/neurosurgery BCI device. CRO or sponsor side experience.
→ neurotechjobs.io
📣 Marketing & Community
Science Corporation MKTG
Head of Demand Gen (Digital Marketing) — $150K–$220K · Alameda CA
PRIMA subretinal prosthesis — demand generation, campaigns, lifecycle marketing. Medtech or ophthalmology a plus.
→ neurotechjobs.io
Cala Health 🔥 SALES
Director, Marketing — $170K–$220K · San Mateo CA
Commercialization lead for FDA-cleared wearable tremor therapy. Full-funnel marketing, diagnostics, regulated device experience required.
→ jobs.gv.com/jobs/cala-health
Attune Neurosciences MKTG
Trial Recruitment Specialist — $75K–$95K · San Francisco CA
Patient recruitment for anesthesiology/BCI trials. Community building, referral programs, site coordination.
→ neurotechjobs.io
🎯 Role Summaries + How to Stand Out
Paradromics — VP Marketing & Brand
What it actually is: This is a founder-level narrative job. Matt Angle (CEO) just completed the first human BCI implant (June 2025). The company is about to raise a landmark round. They're not looking for a product marketer — they're looking for someone who can make Paradromics the Neuralink alternative that institutional VCs and the public believe in. The narrative has to work on patients, investors, regulators, and the scientific community simultaneously.
Participation pointer: Before applying, read Matt Angle's 2024 Nature paper on the neural interface architecture. Come with a one-pager: "Three narratives Paradromics should own that Neuralink can't." That's your interview opener. The VP who walks in knowing the science and the story wins. Follow the company on LinkedIn — Matt Angle posts frequently about BCI milestones. Reference a specific post in your outreach.
MBA edge: You don't need a neuroscience degree — you need to show you can translate "high-density neural recording at 192 channels" into a sentence a pension fund will invest in. Frame it as category creation, not marketing.
Neuralink — Product Operations
What it actually is: Non-technical project coordinator role at the world's most watched BCI company. You'll be the connective tissue between the engineering team (building the N1 chip) and the clinical team (running the PRIME study). Think: timeline management, cross-functional sync, risk tracking, vendor coordination. It's a $68K–$114K ops role — not glamorous, but近距离 the science.
Participation pointer: Study Neuralink's FDA approval journey — the FDA rejected them twice before approving the human trial. Know the specific failure points (N1 chip biocompatibility, animal welfare concerns). Ask during interview: "What was the hardest operational lesson from the FDA rejection and how would you structure the ops process differently?" Shows you did your homework.
MBA edge: MBA gives you the systems-thinking lens: how does a project this complex not fall apart? Frame your experience with multi-stakeholder coordination, not just project management terminology.
LivaNova — Director, Neuromodulation Project Head
What it actually is: P&L owner for a portfolio of neuromodulation devices (VNS therapy for epilepsy, depression). At $215K–$250K, this is medtech scale — LivaNova is public, established, and has an existing salesforce. You're not building a category; you're maximizing an existing one. Strategy + execution across clinical, commercial, and regulatory.
Participation pointer: LivaNova's neuromodulation division has been in steady competition with SetPoint Medical and Synchron. Know the competitive landscape: VNS vs. SCS vs. DBS. Read the last two earnings calls for the neuromodulation segment. Come with a one-slide market view: "Where is the growth vector — refractory depression or chronic pain?"
MBA edge: This is the most MBA-traditional role on the list. The case method training is your advantage here — show structured thinking about portfolio allocation and market entry vs. market deepening. Use frameworks explicitly.
Science Corporation — Head of Demand Generation
What it actually is: Science Corp makes the PRIMA subretinal prosthesis — a retinal implant for blind patients. This is a $150K–$220K demand gen role for a product that has an FDA approval and is currently scaling commercial operations. You're not creating a category; you're activating a patient community that's been waiting for this technology.
Participation pointer: The PRIMA implant has 2-year clinical data showing significant visual acuity improvement. The patient community (retinitis pigmentosa, age-related macular degeneration) is passionate and organized. Know the specific patient advocacy groups — Foundation for Retinal Research, RD Support Group. Your demand gen strategy lives and dies by patient referral networks and ophthalmologist relationships. Read the PRIMA clinical papers (2–3 pages, accessible) and come knowing the activation funnel.
MBA edge: Rare disease + medical device = ultra-specific demand gen. MBA gives you the frameworks for channel strategy and customer acquisition cost modeling that pure marketers miss. Bring a rough CAC analysis for an ophthalmology referral program.
Ampa — Sales Executive
What it actually is: Ampa appears to be a neurotech peripheral or therapeutic device company. The $150K–$190K band + territory management + medical device context suggests a quota-carrying role. Not a startup founder sales hire — an established company building a sales motion. Remote is real here.
Participation pointer: Find Ampa's actual product — search "Ampa neurotech" and "Ampa therapeutics" before applying. The job posting is generic. Know what they actually sell. A candidate who walks in knowing the product landscape in their territory and has a territory build plan in hand is a 10x stronger candidate. Ask in interview: "What's the current channel mix — direct to clinic or distributor model?"
MBA edge: The MBA gives you strategic account planning skills — not just closing, but territory design and long-term relationship architecture. Frame yourself as a strategic territory builder, not a transaction closer.
Theranica — Director of Operations
What it actually is: Theranica makes the Nerivio device — a remote electrical neuromodulation wearable for migraine (FDA-cleared, smartphone-controlled). This is a digital health company scaling product delivery globally. "Product delivery lifecycle" = supply chain + partner channel management + reimbursement ops.
Participation pointer: Theranica just closed a Series C (late 2024). They expanded into Europe. The operational challenge at this stage is typically: scaling from 10K to 100K patients, negotiating with insurers for coverage, managing contract manufacturers. Know the digital health reimbursement landscape — FDA-cleared devices still face insurance coverage gaps. Ask: "Walk me through the payer coverage strategy for Nerivio in the US vs. EU."
MBA edge: Operations in digital health = supply chain + reimbursement + compliance. MBA case prep on CSV (PepsiCo/NNF) is actually relevant here — you're managing a company where the "social value" narrative (migraine relief) and the commercial model have to align. Show you understand the payer landscape.
Attune Neurosciences — Clinical Research Manager
What it actually is: Attune is an early-stage BCI company focused on anesthesiology applications (preventing anesthesia awareness during surgery). The clinical research manager runs trial operations — site management, IRB submissions, patient recruitment, CRO oversight. It's a hands-on, compliance-heavy role.
Participation pointer: Anesthesia awareness during surgery is a $1B+ problem (literature estimate). Attune's solution: a closed-loop EEG-based monitoring system. The trial design question: how do you design a trial for a safety-critical device when "no anesthesia awareness" is the desired outcome? Come knowing the FDA's TAP (Total Product Life Cycle) approach for neurological devices. Ask: "How would you structure the pivotal trial given the safety signal?"
MBA edge: Clinical trial design from a business lens — risk-adjusted trial architecture, CRO vendor selection, site selection for patient diversity. Your MBA training in structured decision-making under uncertainty is directly applicable.
Attune Neurosciences — Trial Recruitment Specialist
What it actually is: Patient recruitment for a surgical trial — patients undergoing general anesthesia who might experience awareness. The job is community building, site coordination, and referral network activation. $75K–$95K reflects the seniority level — this is a doer role, not a manager role.
Participation pointer: Anesthesia awareness patients are a specific, hard-to-reach population — most people don't know they've experienced it until it's identified. Recruitment strategies: pre-op anesthesia education, patient forums (FDA's Patient Representative Program), anesthesiology department partnerships. Come with a 30-60-90 day recruitment plan template and you've already shown you can do the job.
MBA edge: Even for an MBA, this is a "foot in the door" role at a company with potential. The Director path from Clinical Research Manager at Attune is a real trajectory — if the pivotal trial succeeds and the company raises a Series B, the whole clinical org scales. Apply even if you think you're overqualified — the MBA gets you in the door for the next role.
Bottom Line for Jordan
Best single application: Paradromics VP Marketing — highest upside, most aligned with your narrative-building skills, and it comes before a major fundraising. Second: LivaNova Director — most likely to actually hire you, clearest path from MBA to P&L ownership in medtech. The others are real opportunities but require more specific domain knowledge or are harder to land from Madrid.
Job boards: neurotechjobs.io · LinkedIn Neurotech · Wellfound · NeuroTechX

📚 Sources

Neurotech Futures — Notables #55 (Jun 2, 2026), Signals #06 (May 15, 2026) (neurotechnology.substack.com)
Rice University News — Motif Neurotech FDA trial approval (Apr 28, 2026)
SeedTable — 54 BCI startups · 127+ total companies · $5.4B aggregate funding
Neurofounders — BCI funding map and ecosystem directory (neurofounders.co)
CNBC / Tech Press — Human implant milestones and big rounds
Tracxn / Crunchbase — Funding database